The Generics Bulletin Top 50, Part One: Indian Leaders Climb Into Top 10
Dr Reddy’s And Cipla Take Places Among Leading Group Of Off-Patent Industry Peers
In a year that has seen significant changes throughout our generics and biosimilars industry ranking, the top 10 has welcomed two Indian off-patent leaders after two other firms dropped out of the top table. We delve into what has changed in the first instalment of this year’s Generics Bulletin Top 50.
